September 2024 - Triankle | A regenerative therapy for ankle injuries

Walking ahead of performance.

Presentation of the TriAnkle project at the Regenerative Medicine Symposium “Regenera by Isiena”

In August, Mexico City hosted the tenth edition of the Regenerative Medicine Symposium Regenera by Isiena, an event that brought together researchers, doctors and professionals from the pharmaceutical and biotechnology industries to share experiences and knowledge on advanced therapies. The programme included interesting presentations on sustainable regenerative therapies, 3D culture, pluripotent stem cells and musculoskeletal […]

Subscribe to our newsletter

I have read and accept the privacy policy.

In compliance with current regulations on the protection of personal data, we inform you that the information received by Naturin Viscofan GmbH when you fill in the form to receive the newsletter is processed with the utmost confidentiality in order to send you information about the TriAnkle Project. The information received is not used for any other purpose. The personal data collected will be deleted as soon as the data is no longer necessary for the purpose.

You can exercise your rights of access, rectification, opposition, deletion, portability and limitation of data by directing a communication via postal mail to the Data Protection Manager, Badeniastrasse, 13 - 69469 - Weinheim - GERMANY or by sending an email to the following address: dataprot@viscofan.com, indicating in both cases your name, surname and a copy of your identity document.

In case you consider that your rights have been violated or have not been attended to with due diligence, you may file a complaint with the corresponding control authority. If you want to unsubscribe, so you no longer receive these types of messages from us, you can send an email to dataprot@viscofan.com and we shall stop the processing of your data for that purpose.

This project has received funding from the European Union’s Horizon 2020
research and innovation framework programme under the Grant Agreement #952981